Daily BriefsHealthcare

Daily Brief Health Care: Top Glove Corp, Align Technology, Boston Scientific and more

In today’s briefing:

  • Top Glove Corp (TOPG MK): Recovery Continues, ASP Improves, Demand Outlook Stays Strong
  • Align Technology: How a $50,000 Device Is Locking in Doctors & Driving Profits!
  • Boston Scientific: How WATCHMAN and FARAPULSE Expansion Is Shaping This Med-Tech Giant’s Future!


Top Glove Corp (TOPG MK): Recovery Continues, ASP Improves, Demand Outlook Stays Strong

By Tina Banerjee

  • Top Glove Corp (TOPG MK) achieved 70% YoY revenue growth in 1HFY25, while net profit stood at RM 58M.
  • Management remains bullish on the U.S. market with North America region (23% of revenue) witnessing 13% QoQ sales growth in 2QFY25.
  • ASP were up 3–4% across product categories. Top Glove expects the ASP to further strengthen.

Align Technology: How a $50,000 Device Is Locking in Doctors & Driving Profits!

By Baptista Research

  • Align Technology presented a mixed outlook in its latest earnings call for the fourth quarter and full year of 2024.
  • While the company reported positive revenue growth across some segments, several challenges and uncertainties were also highlighted, presenting a balanced investment prospect.
  • On the positive side, Align Technology posted a total revenue increase of 4% year-over-year in the fourth quarter.

Boston Scientific: How WATCHMAN and FARAPULSE Expansion Is Shaping This Med-Tech Giant’s Future!

By Baptista Research

  • The financial results for Boston Scientific’s fourth quarter and full-year 2024 highlight both strengths and challenges faced by the company.
  • Achieving robust growth in several segments, the company reported operational sales growth of 23% for the quarter and 18.5% for the year, with organic growth hitting 20% and 16% respectively.
  • These figures surpass their upper guidance limits, indicating strong market performance, driven primarily by the early U.S. adoption of the FARAPULSE system and other key products.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars